Although the literature is still emerging, in general, studies have observed that COVID-19 patients with controlled HIV coinfection and preserved CD4+ T cell counts have similar clinical trajectories to those without HIV infection (18, 42, 43). The gene discussed is CD4; the disease is COVID-19.